Motesanib or bevacizumab in combination with paclitaxel and carboplatin in patients with advanced nonsquamous non-small cell lung cancer (NSCLC): interim results from a randomized, open-label, phase 2 study
Other conference paper


Times Cited
Web of Science0WOS source URL (as at 05/08/2020) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListBlumenschein G, Schwartzberg LS, Menon H, Mok TSK, Stephenson JJ, Beck JT, Lakshmaiah K, Kracht K, Sikorski R, Kabbinavar F
Name of Conference15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Start Date of Conference20/09/2009
End Date of Conference24/09/2009
Place of ConferenceBerlin
Country/Region of ConferenceGermany
Journal nameEJC Supplements
Detailed descriptionorganized by European Society of Medical Oncology,
Year2009
Month9
Day1
Volume Number7
Issue Number2
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Pages555 - 555
ISSN1359-6349
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology

Last updated on 2020-06-08 at 04:40